16,558 findings · published 2017+
- Energy balanceStrong
There were no significant differences between groups for the remaining outcomes, although a small effect size favoring TRAD was observed for the middle region of the pectoralis major (g = -0.25).
Practitioners should note that while TRAD may have a slight advantage, it is not statistically significant for all outcomes.
Qualifies 2021 - Metabolic adaptationStrong
Using LNCSBs as a substitute for SSBs was associated with small improvements in cardiometabolic risk factors without evidence of harm.
Practitioners can consider LNCSBs as a safe alternative to SSBs for improving health outcomes.
Supports 2024 - Metabolic adaptationStrong
Protein interacts with carbohydrates, fats, and dietary energy density to influence calorie intake and metabolic physiology.
Understanding protein's role can help in designing effective dietary interventions.
Supports 2024 - Energy balanceStrong
Considering interactions among dietary components can help reconcile different models of obesity.
Practitioners should consider dietary interactions when developing obesity interventions.
Supports 2024 - NeuralStrong
The intervention achieved 100% attendance and adherence to self-monitoring.
Practitioners can implement remote monitoring strategies to enhance adherence in older adults.
Supports 2024 - Energy balanceStrong
PA at months 2 to 4 was significantly correlated with PA at 1 year (rs = .29-.35, P < .01).
Early engagement in physical activity can predict long-term adherence.
Supports 2020 - Metabolic adaptationStrong
Older patients were 3% more likely to have weight loss (odds ratio [OR], 1.03; 95% confidence interval [CI], 1.02–1.05).
Practitioners should consider age as a factor when assessing weight loss potential in T2D patients.
Supports 2019 - Energy balanceStrong
Reductions in fat mass were similar across all protein intake groups, with LP, MP, and HP showing reductions of 1.7%, 3.7%, and 3.1% respectively (P > 0.05).
Fat loss outcomes may not significantly differ based on protein intake levels in older women undergoing resistance training.
Supports 2022 - Energy balanceStrong
Tirzepatide achieved similar 12-month TBWL% as R-ESG (13.2% vs. 13.4%, p = .9) and significantly more than semaglutide (13.2% vs. 8.1%, p = .04).
Tirzepatide may be a viable alternative for weight loss in patients post-sleeve gastrectomy, potentially outperforming semaglutide.
Supports 2025New - Energy balanceStrong
The policy of Nutrition Facts added-sugar labeling is associated with a reduction of 30,000 new cancer cases and 17,100 cancer deaths among US adults over a lifetime.
Implementing added-sugar labeling could significantly reduce cancer incidence and mortality.
Supports 2021 - Energy balanceStrong
The policy is associated with a gain of 116,000 quality-adjusted life-years (QALYs) among US adults.
The policy could lead to significant improvements in life quality and longevity.
Supports 2021 - Energy balanceStrong
Additional industry reformulation to reduce added-sugar amounts would double the impact of the policy.
Encouraging food industry reformulation could significantly enhance public health outcomes.
Supports 2021 - Energy balanceStrong
Both FDA-approved gastric balloon systems (gas-filled IGB and fluid-filled IGB) had the same effectiveness in terms of percent total body weight loss at balloon removal.
Both balloon systems can be considered equally effective for weight loss.
Supports 2022 - CellularStrong
The gas-filled IGB had fewer serious adverse events and better tolerability than the fluid-filled IGB.
The gas-filled IGB may be a safer option for patients.
Supports 2022 - Energy balanceStrong
The implementation of a pharmacist-led weight management clinic resulted in an estimated cost savings of $101,985.66.
Pharmacist involvement can lead to significant cost savings in weight management programs.
Supports 2022 - HormonalStrong
Females tended to lose more weight (Mean = 9.75) than males (Mean = 8.41).
Practitioners may consider gender differences when designing weight-loss interventions.
Supports 2024 - NeuralStrong
The semaglutide group mostly showed higher RSFC after the intervention, while the placebo group mostly showed lower RSFC in a selection of investigated ROIs.
This suggests that semaglutide may influence RSFC positively, but the clinical significance remains uncertain.
Qualifies 2023 - Metabolic adaptationStrong
The animal-based, ketogenic diet led to increased blood ketones of ~3 mM, which is thought to suppress appetite.
Practitioners may consider the appetite-suppressing effects of ketogenic diets due to increased ketone levels.
Supports 2020 - NeuralStrong
High carbohydrate intake is associated with a higher risk of dementia (HR 1.48 (95%CI: 1.15-1.91)), while low carbohydrate intake is not significantly associated.
Practitioners should consider advising older adults to moderate their carbohydrate intake to potentially reduce dementia risk.
Supports 2021 - NeuralStrong
Moderate intakes of carbohydrate, fat, and protein are associated with the lowest risk of incident dementia.
Practitioners should encourage older adults to maintain a balanced intake of macronutrients to potentially lower dementia risk.
Supports 2021 - CellularStrong
There were no significant differences between groups for the remaining outcomes, although a small effect size favoring TRAD was observed for the middle region of the pectoralis major (g = -0.25).
Practitioners should note that while TRAD may have a slight advantage, it is not statistically significant for all outcomes.
Qualifies 2021 - Energy balanceStrong
Discontinuation rates were strongly associated with copayment amount, increasing from 41% in the lowest quintile to 51% in the highest quintile.
Financial considerations significantly impact patient adherence to semaglutide treatment.
Supports 2025New - Energy balanceStrong
A higher carbohydrate quality index (CQI) is associated with greater micronutrient consumption adequacy in Iranian adults.
Encouraging higher CQI may enhance overall nutrient adequacy in dietary practices.
Supports 2021 - Energy balanceStrong
Minimally invasive bariatric surgeries, endoscopic procedures, fecal microbiota transplants (FMTs), and pharmaceuticals like GLP-1 receptor agonists show promising results for obesity treatment.
Practitioners should consider these innovative treatment options for obesity management.
Supports 2024